Composition
- Active ingredients
- DESIRUDIN RECOMBINANT 15MG/VIAL
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application BLA021271.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Iprivask
- Active substance
- desirudin recombinant
- Route
- Subcutaneous
- Dosage form
- Injectable
- Applicant
- Bausch
- Status
- Discontinued
- FDA approval
- 4 Apr 2003
- Application
- BLA021271-001